全球研究用抗體和試劑市場規模、佔有率、趨勢和成長分析報告，2026-2034年

研究用抗體和試劑市場預計將從 2025 年的 151.1 億美元成長到 2034 年的 273.4 億美元，2026 年至 2034 年的複合年成長率為 6.81%。

受生命科學研究的拓展、生物技術的創新以及診斷技術的發展所驅動，全球科研用抗體和試劑市場正快速成長。抗體和試劑是分子生物學、免疫學和細胞分析等領域中不可或缺的工具。生物醫學研究經費的增加以及製藥領域研發投入的擴大，正推動市場需求的穩定成長。

關鍵成長要素包括蛋白質體學、基因組學和個人化醫療研究的進步。單株抗體和重組抗體生產技術的改進提高了特異性和可重複性。學術機構、合約研究組織 (CRO) 和生物技術公司是主要終端用戶。新冠肺炎疫情進一步凸顯了快速診斷和治療研究工具的重要性。

展望未來，隨著細胞和基因治療研究以及生物標記發現的拓展，需求預計將持續成長。標準化和提高可重複性對於維持研究品質至關重要。新興市場對生命科學基礎設施的投資可望帶來新的成長機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球科研用抗體與試劑市場：依類型分類

• 市場分析、洞察與預測
• 抗體
• 試劑

第5章：全球研究用抗體與試劑市場：依應用分類

• 市場分析、洞察與預測
• 酵素免疫分析法
• 蛋白質印跡法
• 免疫組織化學
• 流式細胞技術
• 聚合酵素鏈鎖反應
• 其他

第6章：全球研究用抗體與試劑市場：依研究領域分類

• 市場分析、洞察與預測
• 免疫學
• 細胞/分子生物學
• 神經科學
• 基因組學和蛋白​​質組學
• 生物技術和藥物發現
• 微生物學
• 其他

第7章 全球研究用抗體和試劑市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物製藥製造商
• 學術研究機構
• 受託研究機構（CRO）
• 醫院/診斷實驗室
• 其他

第8章：全球科學研究抗體與試劑市場：按分銷管道分類

• 市場分析、洞察與預測
• 直銷
• 第三方銷售
• 其他

第9章：全球研究用抗體和試劑市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和分銷通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific
  • MilliporeSigma
  • Santa Cruz BIoTechnology
  • Danaher
  • Perkinelmer Inc
  • F. Hoffmann La Roche Ltd
  • Rockland Immunochemicals Inc
  • Johnson & Johnson
  • Agilent Technologies Inc
  • Eli Lilly And Company
  • BD
  • Genscript BIoTech Corporation

The Research Antibodies & Reagents Market size is expected to reach USD 27.34 Billion in 2034 from USD 15.11 Billion (2025) growing at a CAGR of 6.81% during 2026-2034.

The global research antibodies and reagents market has grown rapidly with expanding life sciences research, biotechnology innovation, and diagnostic development. Antibodies and reagents are critical tools in molecular biology, immunology, and cell-based assays. Increased funding for biomedical research and rising pharmaceutical R&D investments drive steady demand.

Key drivers include growth in proteomics, genomics, and personalized medicine research. Advances in monoclonal and recombinant antibody production enhance specificity and reproducibility. Academic institutions, CROs, and biotech firms represent major end-users. The COVID-19 pandemic further underscored the importance of rapid diagnostic and therapeutic research tools.

Looking ahead, demand will continue to rise with expanding cell and gene therapy research and biomarker discovery. Standardization and reproducibility improvements will be critical to maintaining research quality. Emerging markets investing in life sciences infrastructure will provide new growth avenues.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Antibodies
• Reagents

By Application

• Enzyme-Linked Immunosorbent Assay
• Western Blotting
• Immunohistochemistry
• Flow Cytometry
• Polymerase Chain Reaction
• Others

By Research Area

• Immunology
• Cell & Molecular Biology
• Neuroscience
• Genomics & Proteomics
• Biotechnology & Drug Discovery
• Microbiology
• Others

By End User

• Pharmaceutical and Biopharmaceutical Manufacturers
• Academic and Research Institutes
• Contract Research Organizations (CROs)
• Hospitals & Diagnostic Laboratories
• Others

By Distribution Channel

• Direct Sales
• Third Party Sales
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific, MilliporeSigma, Santa Cruz Biotechnology, Danaher, Perkinelmer Inc, F Hoffmann La Roche Ltd, Rockland Immunochemicals Inc, Johnson Johnson, Agilent Technologies Inc, Eli Lilly and Company, BD, Genscript Biotech Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Enzyme-Linked Immunosorbent Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Western Blotting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Immunohistochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Flow Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Polymerase Chain Reaction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET: BY RESEARCH AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Research Area
• 6.2. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cell & Molecular Biology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neuroscience Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Genomics & Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Biotechnology & Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Microbiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceutical and Biopharmaceutical Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Hospitals & Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Distribution Channel
• 8.2. Direct Sales Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Third Party Sales Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Type
  • 9.2.2 By Application
  • 9.2.3 By Research Area
  • 9.2.4 By End User
  • 9.2.5 By Distribution Channel
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Type
  • 9.3.2 By Application
  • 9.3.3 By Research Area
  • 9.3.4 By End User
  • 9.3.5 By Distribution Channel
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Type
  • 9.4.2 By Application
  • 9.4.3 By Research Area
  • 9.4.4 By End User
  • 9.4.5 By Distribution Channel
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Type
  • 9.5.2 By Application
  • 9.5.3 By Research Area
  • 9.5.4 By End User
  • 9.5.5 By Distribution Channel
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Type
  • 9.6.2 By Application
  • 9.6.3 By Research Area
  • 9.6.4 By End User
  • 9.6.5 By Distribution Channel
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL RESEARCH ANTIBODIES & REAGENTS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Thermo Fisher Scientific
  • 11.2.2 MilliporeSigma
  • 11.2.3 Santa Cruz Biotechnology
  • 11.2.4 Danaher
  • 11.2.5 Perkinelmer Inc
  • 11.2.6 F. Hoffmann La Roche Ltd
  • 11.2.7 Rockland Immunochemicals Inc
  • 11.2.8 Johnson & Johnson
  • 11.2.9 Agilent Technologies Inc
  • 11.2.10 Eli Lilly And Company
  • 11.2.11 BD
  • 11.2.12 Genscript Biotech Corporation